MedTrace Logo

Study of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy Volunteers

NCT00935233 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2013-08-12

No results posted yet for this study

Summary

RATIONALE: Studying genes in samples of blood and/or tumor tissue from patients with cancer may help doctors identify biomarkers related to cancer.

PURPOSE: This research study is looking at blood and/or tumor tissue samples from patients with ductal carcinoma in situ and blood samples from healthy volunteers.

Conditions

Interventions

GENETIC

DNA analysis

GENETIC

polymorphism analysis

GENETIC

protein analysis

OTHER

laboratory biomarker analysis

OTHER

questionnaire administration

OTHER

survey administration

Sponsors & Collaborators

  • Queen Mary University of London

    lead OTHER

Principal Investigators

  • Rebecca Roylance, MD · Barts and the London School of Medicine and Dentistry

  • Elinor Sawyer, MD · Cancer Research UK

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2010-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00935233 on ClinicalTrials.gov